###begin article-title 0
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
###xml 87 87 87 87 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 87 87 87 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
###xml 87 87 87 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref>
Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide*
###end article-title 0
###begin p 1
Supported by a CIHR fellowship.
###end p 1
###begin p 2
Both authors contributed equally to this work.
###end p 2
###begin p 3
Innate defense regulator-1 (IDR-1) is a synthetic peptide with no antimicrobial activity that enhances microbial infection control while suppressing inflammation. Previously, the effects of IDR-1 were postulated to impact several regulatory pathways including mitogen-activated protein kinase (MAPK) p38 and CCAAT-enhancer-binding protein, but how this was mediated was unknown. Using a combined stable isotope labeling by amino acids in cell culture-proteomics methodology, we identified the cytoplasmic scaffold protein p62 as the molecular target of IDR-1. Direct IDR-1 binding to p62 was confirmed by several biochemical binding experiments, and the p62 ZZ-type zinc finger domain was identified as the IDR-1 binding site. Co-immunoprecipitation analysis of p62 molecular complexes demonstrated that IDR-1 enhanced the tumor necrosis factor alpha-induced p62 receptor-interacting protein 1 (RIP1) complex formation but did not affect tumor necrosis factor alpha-induced p62-protein kinase zeta complex formation. In addition, IDR-1 induced p38 MAPK activity in a p62-dependent manner and increased CCAAT-enhancer-binding protein beta activity, whereas NF-kappaB activity was unaffected. Collectively, these results demonstrate that IDR-1 binding to p62 specifically affects protein-protein interactions and subsequent downstream events. Our results implicate p62 in the molecular mechanisms governing innate immunity and identify p62 as a potential therapeutic target in both infectious and inflammatory diseases.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN5"><sup>4</sup></xref>
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 380 359 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 403 415 403 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enteroccocus</italic>
###xml 421 440 421 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella enterica</italic>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 792 793 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 359 380 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 421 440 <span type="species:ncbi:28901">Salmonella enterica</span>
Innate defense regulator-1 (IDR-1)4 (KSRIVPAIPVSLL-NH2) is a synthetic peptide with no antimicrobial activity that enhances host bacterial infection control while suppressing harmful inflammation. Treatment of mice with IDR-1 provides protection from otherwise lethal infections with Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enteroccocus, and Salmonella enterica (1). In addition, IDR-1 enhances production of some monocyte-produced chemokines, including MCP-1 and RANTES (regulated on activation normal T cell expressed and secreted) and the anti-inflammatory cytokine interleukin-10. IDR-1 also suppresses production of Toll-like receptor-induced proinflammatory cytokines, including interleukin-6 and TNFalpha (1). Previously, the effects of IDR-1 were postulated to impact several intracellular pathways, including MAPK p38 and C/EBP, but the preceding molecular events remained unknown.
###end p 5
###begin p 6
###xml 213 214 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 216 217 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 225 226 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 235 236 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 250 251 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 347 348 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 411 412 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 472 473 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 555 556 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 721 722 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 861 862 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 864 866 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 983 985 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 987 989 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1021 1023 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
In this study, the cytoplasmic protein sequestosome-1 (p62) was identified as a molecular target of IDR-1. p62 is a multidomain scaffold (adaptor) protein, with many known interacting partners, including PKCzeta (2, 3), p38 (4), RIP1 (5), and TRAF6 (6). p62 comprises an N-terminal PB1 domain that is primarily important for atypical PKC binding (2), a ZZ-type zinc finger (ZZ) domain that interacts with RIP1 (5), and a TRAF6 binding sequence domain recognized by TRAF6 (6). Additionally, a C-terminal ubiquitin-associated domain binds to polyubiquitin (7), a function recently demonstrated to facilitate the efficient activation of prosurvival and proapoptotic pathways by binding polyubiquitinated signaling proteins (8). The ubiquitin-associated domain is also considered the basis for the association between p62 and protein trafficking to the proteasome (9, 10). Thus, p62 functions as a nodal point in cellular signaling pathways, particularly in the regulation of NF-kappaB (11, 12) and cellular differentiation (13).
###end p 6
###begin p 7
Here we provide evidence that IDR-1 specifically binds to the ZZ domain of p62. This binding event selectively stabilized TNFalpha-induced p62-RIP1 complex formation, but not TNFalpha-induced p62-PKCxi complex formation, and specifically modulated the downstream signaling pathways by activating MAPK p38 and C/EBPbeta but not NF-kappaB. These studies provide new evidence for p62 as an important component of the immune system and demonstrate that IDR-1 can be used for the interrogation of the molecular events governing these innate responses.
###end p 7
###begin title 8
EXPERIMENTAL PROCEDURES
###end title 8
###begin p 9
Experimental Procedures are detailed in the .
###end p 9
###begin title 10
RESULTS
###end title 10
###begin title 11

###end title 11
###begin title 12

###end title 12
###begin title 13
p62 Is an Intracellular Target of IDR-1
###end title 13
###begin p 14
###xml 296 298 296 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 299 300 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 315 316 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 632 638 632 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1024 1030 1024 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1030 1031 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1144 1150 1144 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1150 1151 1150 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1153 1164 1153 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 188 194 <span type="species:ncbi:10090">Murine</span>
We utilized stable isotope labeling by amino acids in cell culture (SILAC) and quantitative mass spectrometry-based proteomics to identify the major intracellular binding target of IDR-1. Murine leukemic RAW264.7 cells were grown in isotopically labeled medium (SILAC-heavy condition containing [13C6]arginine and [2H4]lysine) and in isotopically unlabeled medium (SILAC-light condition containing normal isotopic arginine and lysine) (14). The cells from both conditions were harvested, lysed, and subjected to affinity enrichment with desthiobiotinylated IDR-1 (heavy condition) or desthiobiotin alone (light, control condition) (Fig. 1A). Proteins bound to the matrix after washing were eluted using free biotin, digested to peptides, and analyzed by liquid chromatography-tandem mass spectrometry. Quantitative SILAC ratios were then extracted after acquisition. Only two cellular proteins, p62 and XIAP-4, showed a marked and consistent differential binding to IDR-1 when compared with control in three repeat studies (Fig. 1B). p62 was present with a specific/nonspecific (Sp:nSp) ratio approaching infinity indicating selective binding (Fig. 1C, right panel). This analysis was confirmed using other, related IDR compounds, which detected only p62, but not XIAP-4, as the binding partner (not shown).
###end p 14
###begin p 15
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDR-1 binds to sequestosome-1/p62.</bold>
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 750 751 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 904 912 904 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lines. C</italic>
###xml 947 957 947 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 1126 1130 1111 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1200 1211 1185 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 1359 1363 1344 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1493 1494 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1617 1618 1602 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1643 1644 1628 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1679 1680 1664 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 1772 1782 1757 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 1812 1823 1797 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 1826 1827 1811 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1866 1874 1851 1859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2006 2016 1991 2001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Error bars</italic>
###xml 1511 1516 <span type="species:ncbi:9606">human</span>
###xml 1856 1861 <span type="species:ncbi:9606">human</span>
IDR-1 binds to sequestosome-1/p62.A, schematic representation of the SILAC-proteomics approach utilized for the identification of the IDR-1 target. Streptavidin beads coated with desthiobiotinylated IDR-1 or desthiobiotin alone (negative control) were incubated with lysates prepared from SILAC-labeled and unlabeled RAW264.7 cells, respectively, followed by liquid chromatography-tandem mass spectrometry analysis of the combined bead eluent. Spectra derived from SILAC-labeled proteins and unlabeled proteins are presented as Sp and nSp. IDR-1 binding partners are identified by having an Sp:nSp ratio greater than 1. Proteins bound to the desthiobiotin control will produce Sp:nSp ratios close to or less than 1 and constitute background binders. B, proteins detected in the IDR-1 pulldown. Only proteins that were detected in more than one experiment are presented. p62 and XIAP-4 are highlighted by lines. C, IDR-1 interacts with p62. In the left panel, spectra from representative peptides of a non-specifically binding protein (GRP78) showed similar signals of the labeled (▲) and unlabeled (big up tri, open) protein, i.e. the ratio of peak intensities of Sp over nSp is close to 1.0. In the right panel, spectra from representative peptides of p62 (SQSTM1) are observed only in the labeled condition, indicating the specific binding of p62 to IDR-1, i.e. the ratio of peak intensities of Sp over nSp is close to infinity. These data are representative of three replicate experiments. D, IDR-1 binds to human p62, but only weakly to XIAP. Lysates from HEK293T cells were pulled down against biocytin control (C) or biotinylated IDR-1 (P). Cell lysates are designated as (L) and were used as control. Proteins pulled down were immunoblotted with anti-p62 antibody (left panel) or with anti-XIAP antibody (right panel). E, IDR-1 binds to recombinant human p62 in vitro. Direct p62 binding by IDR-1 (●) or biocytin control (■) was determined using a plate coated with various concentrations of IDR-1. Error bars represent S.D.
###end p 15
###begin p 16
###xml 322 328 310 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 328 329 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 331 341 319 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 619 625 607 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 625 626 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 628 639 616 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
To test direct binding of IDR-1 to human p62 and XIAP, lysates from HEK293T cells were incubated with streptavidin beads coated with biotinylated IDR-1 or biocytin as background control. Immunoblot analysis of the pulldown samples showed a strong band at approximately62 kDa that was detected with antibodies against p62 (Fig. 1D, left panel). Densitometric analysis of this band revealed that it constitutes 64% of the intensity of p62 present in the cell lysate control, suggesting that the majority of the p62 from the lysate bound to the peptide. In contrast, the IDR-1 pulldown of the XIAP protein was very faint (Fig. 1D, right panel) and constituted only 4% of the lysate control.
###end p 16
###begin p 17
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 228 234 228 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 613 618 <span type="species:ncbi:9606">human</span>
We next investigated direct IDR-1 binding to recombinant human p62. To test this, an in vitro protein binding assay using biotinylated IDR-1 and human recombinant glutathione S-transferase-labeled p62 was performed. As shown in Fig. 1E, a concentration-dependent binding of p62 by IDR-1 was observed, whereas the control biocytin did not bind to p62 over the same concentration range. This binding was confirmed using a competitive binding experiment with biotinylated IDR-1 and unlabeled IDR-1 and with other IDR analogs in the same class (data not shown). These results confirmed direct binding of IDR-1 to the human p62 protein.
###end p 17
###begin title 18
IDR-1 Binds to the ZZ Domain of p62
###end title 18
###begin p 19
###xml 104 110 104 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 321 326 321 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;117</sup>
###xml 331 338 331 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118&#8211;440</sup>
###xml 347 354 347 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">267&#8211;440</sup>
###xml 393 398 393 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;117</sup>
###xml 406 413 406 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">267&#8211;440</sup>
###xml 438 445 438 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118&#8211;440</sup>
###xml 447 453 447 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 520 527 520 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118&#8211;266</sup>
###xml 991 997 991 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 76 81 <span type="species:ncbi:9606">human</span>
To determine which region of p62 is required for IDR-1 binding, FLAG-tagged human p62 deletion mutants (Fig. 2A) were transfected into HEK293T cells and tested in biotinylated IDR-1 pulldown assays, as described above. Initially, the analysis was focused on the N-terminal, central, and C-terminal regions (constructs p621-117, p62118-440, and p62267-440). IDR-1 did not bind to constructs p621-117 and p62267-440, whereas it bound to p62118-440 (Fig. 2B). Further, a p62 construct composed only of residues 118-266 (p62118-266) was also able to bind IDR-1. This central region of p62 (residues 118-266) is made up of three subdomains, including a ZZ (zinc finger) structural motif (residues 128-163), an intermediate domain LB (residues 170-220), and a TRAF6 binding region (residues 225-251). Successive deletions of each of these subdomains revealed that removal of residues 128-163 was sufficient to abolish IDR-1 binding, whereas deletion of LB or TRAF6 domains did not affect binding (Fig. 2). These findings demonstrated that the ZZ domain of p62 is required for IDR-1 binding.
###end p 19
###begin p 20
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDR-1 binds to the ZZ domain of p62.</bold>
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SH2</italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AID</italic>
###xml 246 248 246 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LB</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEST</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LIR</italic>
###xml 367 370 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBA</italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 589 590 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 615 616 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 633 634 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 544 549 <span type="species:ncbi:9606">human</span>
IDR-1 binds to the ZZ domain of p62.A, schematic representation of the constructs used for mapping of the p62 domains that interact with IDR-1. SH2, an SH2 binding domain; AID, an acidic interaction domain (PB1 domain comprises the SH2 and AID); LB, LIM protein Ajuba binding domain; PEST, amino acids Pro, Glu, Ser, Thr-enriched domain; LIR, LC3-interacting region; UBA, ubiquitin-associated domain. B, analysis of IDR-1 pulldown assays with constructs presented in A. Lysates from HEK293T cells overexpressing FLAG-tagged deletion mutants of human p62 were pulled down against biocytin (B) or biotinylated IDR-1 (P). Cell lysates (L) were used as control. Proteins pulled down were immunoblotted with anti-FLAG antibody.
###end p 20
###begin title 21
IDR-1 Selectively Affects p62 Complex Formation
###end title 21
###begin p 22
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 664 670 656 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 670 671 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
The p62 protein is a critical signaling component that functions as a scaffold by forming multiple intracellular protein signaling complexes. Because IDR-1 bound to p62 directly, we investigated the consequences of this binding on intracellular p62 protein complex formation. Sanz et al. (5, 6) previously reported that TNFalpha receptor ligation stimulates complex formation between RIP1 and p62 via the ZZ domain of p62. Thus, we hypothesized that the p62-RIP1 complex formation might be affected in cells treated with IDR-1. In HEK293T cells overexpressing RIP1, IDR-1 induced an increase in TNFalpha-stimulated complex formation between RIP1 and p62 proteins (Fig. 3A), suggesting that IDR-1 increased or stabilized this complex formation.
###end p 22
###begin p 23
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDR-1 selectively affects intracellular p62 complex formation and signaling pathways.</bold>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 252 253 247 248 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 313 315 308 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</italic>
###xml 359 361 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IB</italic>
###xml 403 404 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 561 562 548 549 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 709 710 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 930 932 911 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DN</italic>
###xml 937 944 918 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118&#8211;440</sup>
###xml 1115 1116 1095 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1192 1202 1172 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Error bars</italic>
###xml 1221 1227 1201 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&#8211;E. D</italic>
###xml 1606 1607 1560 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1702 1703 1652 1653 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1748 1751 1698 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPS</italic>
###xml 1828 1829 1775 1776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
IDR-1 selectively affects intracellular p62 complex formation and signaling pathways.A, IDR-1 enhances the p62 and RIP1 complex formation. HEK293T cells overexpressing RIP1 were stimulated with 100 ng/ml TNFalpha for 2 min with or without IDR-1 (200 mum) pretreatment for 30 min. Lysates were immunoprecipitated (IP) with anti-p62 antibody and immunoblotted (IB) with anti-RIP1 and anti-p62 antibodies. B, IDR-1 has no effect on the p62 and PKCzeta complex formation. HEK293T cells were stimulated with 100 ng/ml TNFalpha for 2 min with or without IDR-1 (200 mum) pretreatment for 30 min. Lysates were immunoprecipitated with anti-PKCzeta antibody and immunoblotted with anti-p62 and anti-PKCzeta antibodies. C, IDR-1 treatment activates MAPK p38 in a p62-dependent manner. A549 cells were co-transfected with the PathDetect CHOP trans luciferase reporting system (Stratagene) for p38 activity and a p62 dominant-negative mutant (DN, p62118-440) or empty vector. 24 h after transfection, cells were untreated or treated with 200 mug/ml IDR-1, and p38 phosphorylation-dependent luciferase activity was analyzed. **, p < 0.01. The result is representative of an experiment repeated five times. Error bars represent S.D. in C-E. D, IDR-1 does not modulate NF-kappaB activity in a HEK293T NF-kappaB reporter cell line. Cells were pretreated with IDR-1 at 100 or 300 mug/ml, with or without 100 ng/ml TNFalpha stimulation. TNFalpha stimulation alone was used as control. Pretreatment with 100 or 300 mug/ml LL-37 prior to TNFalpha stimulation was used as a control for peptide modulation of NF-kappaB activity. E, treatment of A549 cells with IDR-1 induces C/EBPbeta activity. Cells were treated with 200 mum IDR-1 or with 100 ng/ml lipopolysaccharide (LPS), and C/EBPbeta activity was detected by enzyme-linked immunosorbent assay. F, proposed model of IDR-1 mechanism of action via p62. IDR-1 binds to the ZZ domain on the p62 protein. This event results in stabilization of the intracellular complex with RIP1. IDR-1 interaction with p62 activates the p38 MAPK pathway, which results in activation of the transcription factor C/EBPbeta. In the presence of TNFalpha stimulation, the NF-kappaB pathway is activated, although IDR-1 does not change complex formation with PKCzeta nor, consequently, modulate NF-kappaB activity. Activation of transcriptional complexes results in modulation of cytokine/chemokine production in anti-infectious and inflammatory immune responses.
###end p 23
###begin p 24
###xml 47 49 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 233 234 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 536 542 512 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 542 543 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
p62 interacts with PKCzeta via its PB1 domain (15), distinct from the IDR-1 binding ZZ domain, and has been postulated as a molecular link between the atypical PKC-dependent NF-kappaB activation and the TNFalpha-RIP1 signaling axes (5). Therefore, the effect of IDR-1 on p62-PKCzeta complex formation was also investigated. IDR-1 pretreated or untreated parental HEK293T cells were stimulated with TNFalpha followed by PKCzeta immunoprecipitation. The amount of p62 co-immunoprecipitated with PKCzeta was unaffected by IDR-1 treatment (Fig. 3B), suggesting that IDR-1 does not alter the TNFalpha-induced complex formation between PKCzeta and p62.
###end p 24
###begin title 25
IDR-1 Selectively Affects Cellular Signaling Pathways
###end title 25
###begin p 26
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 446 453 446 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118&#8211;440</sup>
###xml 686 692 686 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 692 693 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
Complexes formed by p62 protein interactions regulate several intracellular signaling pathways (10, 16). Previously, independent studies have shown that p62 is involved in the p38 MAPK cascade (4) and that IDR-1-modulated cytokine production is linked to p38 (1). To investigate whether IDR-1 affects p38 MAPK signaling through p62, we utilized an approach based on a luciferase reporter of p38 activity and a dominant-negative mutant of p62 (p62118-440 cloned in pcDNA3.1) in the A549 epithelial cell line. IDR-1 treatment of these cells co-transfected with p38 activity reporter plasmids and an empty vector (pcDNA3.1) induced luciferase expression, indicating the activation of p38 (Fig. 3C). This effect was abolished in cells co-transfected with the dominant-negative mutant of p62, suggesting that p38 activation by IDR-1 is mediated by p62.
###end p 26
###begin p 27
###xml 111 113 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 445 451 414 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 451 452 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 658 660 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
The p62 protein has been reported to play a role in NF-kappaB activation by serving as a scaffold for PKCzeta (17). Given the central role of NF-kappaB in cell signaling, we evaluated the effect of IDR-1 on NF-kappaB activity using a HEK293T NF-kappaB luciferase reporter cell line. The treatment of unstimulated cells with IDR-1 did not induce NF-kappaB activation, in contrast to the high NF-kappaB activation induced by TNFalpha stimulation (Fig. 3D). Furthermore, pretreatment with IDR-1 did not alter the NF-kappaB activation by TNFalpha, whereas the cationic peptide LL-37 reduced NF-kappaB activity in a dose-dependent manner, as previously reported (18). These experiments were repeated in an A549 NF-kappaB luciferase reporter cell line with similar results (not shown).
###end p 27
###begin p 28
###xml 197 198 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 290 292 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 294 296 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 485 491 472 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 491 492 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 539 540 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Because NF-kappaB activity did not appear to be affected by IDR-1 treatment of cells, we investigated the IDR-1 effects on C/EBPbeta given our previous findings of IDR-1 induction of this pathway (1) and the known role of p38 in the activation of the C/EBP family of transcription factors (19, 20). An induction of C/EBPbeta activity at 30 and 60 min after IDR-1 treatment was observed in nuclear extracts of A549 cells assayed by C/EBPbeta specific enzyme-linked immunosorbent assay (Fig. 3E). These experiments confirm earlier findings (1) and indicate that C/EBPbeta activity, but not NF-kappaB activity, is modulated by IDR-1 treatment of cells.
###end p 28
###begin title 29
DISCUSSION
###end title 29
###begin p 30
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">&#8211;</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
The intracellular signaling network in host cells allows for efficient communication between the sensing of an incoming pathogen and the initiation of anti-infective responses. The p62 protein is emerging as one of the central signaling hubs of the cell, controlling this process (8-10, 21).
###end p 30
###begin p 31
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 546 551 <span type="species:ncbi:9606">human</span>
The data presented here demonstrate direct binding of IDR-1 to p62 and provide evidence that this binding has specific consequences on protein-protein interactions, as well as on downstream signaling pathways. p62 was discovered as the intracellular target of IDR-1 by an unbiased, non-hypothesis-driven proteomics approach. Due to high affinity of IDR-1 for p62, it is likely that p62 is the most physiologically relevant target. Although we identified XIAP-4 in the SILAC experiments, strong direct binding of IDR-1 to XIAP was not detected in human cell lysates, nor was binding to XIAP detected with other related IDR peptides that did bind p62. Another IDR-1 weak binding partner, glyceraldehyde 3-phosphate dehydrogenase, was also recently described (22).
###end p 31
###begin p 32
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
Human p62 was confirmed as the IDR-1 target using binding assays and pulldown experiments from both endogenous and p62-overexpressing cell lysates. IDR-1 binding to both human and mouse p62, which share 99% amino acid sequence identity, was demonstrated. Through the investigation of p62 deletion mutants, we discovered that IDR-1 binds to the ZZ domain of p62, a zinc-binding protein interaction domain. Most compounds that act on protein-protein interactions antagonize or inhibit complex formation, but IDR-1 addition to cells led to a surprisingly specific effect; the TNFalpha-dependent receptor signaling complex of RIP1 and p62, which occurs at the ZZ domain, was stabilized, whereas the p62-PKCzeta complex, which occurs at the PB1 domain proximal to the RIP1 binding region, was not affected.
###end p 32
###begin p 33
###xml 263 265 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 267 269 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 506 508 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 647 648 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1031 1037 1006 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1037 1038 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
The specific modulation of p62 signaling complexes by IDR-1 appears to have a corresponding effect on the downstream signaling. On one hand, p62 has been described as an activator of NF-kappaB due to its receptor-induced signaling complex formation with PKCzeta (11, 12), but IDR-1 treatment did not modulate NF-kappaB activity downstream of TNFalpha, consistently with the p62-PKCzeta complex formation being unaffected. On the other hand, p38 MAPK activation downstream of TNFalpha is regulated by RIP1 (23), and the increase of RIP1-p62 interaction by IDR-1 may explain the previously reported role of IDR-1 in p38-mediated signaling pathways (1). This is further strengthened by the observation that IDR-1-mediated activation of p38 is dependent on p62. The IDR-1-induced activation of C/EBPbeta, downstream of p38, is also consistent with these and previous findings. Thus, we propose that the specific effects on intracellular signaling presented here contribute to the previously described IDR-1-modulated cytokine profile (Fig. 3F).
###end p 33
###begin p 34
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
IDR-1 has been demonstrated to prevent and treat infections and reduce associated inflammation (1). In addition, recent studies report that p62 expression contributes to regulating macrophage-mediated (21) and cancer-associated inflammation (11, 16, 24), raising the question as to whether IDR-1 might also affect inflammatory responses in the absence of pathogen stimulation. The discovery that p62 is the target of IDR-1 highlights the importance of p62 in innate immunity and reveals p62 as a potential therapeutic target for anti-infective therapy without induction of harmful inflammation, and conversely, potential anti-inflammatory therapy with added anti-infective function.
###end p 34
###begin p 35
This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR) and the Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative (to B. B. F.).
###end p 35
###begin p 36
The on-line version of this article (available at ) contains ."
###end p 36
###begin p 37
###xml 28 31 28 31 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">IDR</term>
###xml 31 55 31 55 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">innate defense regulator</p>
###xml 31 55 31 55 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">innate defense regulator</p></def>
###xml 28 55 28 55 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">IDR</term><def><p textid="38">innate defense regulator</p></def></def-item>
###xml 55 60 55 60 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">C/EBP</term>
###xml 60 90 60 90 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="39">CCAAT-enhancer-binding protein</p>
###xml 60 90 60 90 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="39">CCAAT-enhancer-binding protein</p></def>
###xml 55 90 55 90 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">C/EBP</term><def><p textid="39">CCAAT-enhancer-binding protein</p></def></def-item>
###xml 90 99 90 95 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">NF-&#954;B</term>
###xml 99 161 95 153 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">nuclear factor &#954;-light-chain-enhancer of activated B cells</p>
###xml 99 161 95 153 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">nuclear factor &#954;-light-chain-enhancer of activated B cells</p></def>
###xml 90 161 90 153 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">NF-&#954;B</term><def><p textid="40">nuclear factor &#954;-light-chain-enhancer of activated B cells</p></def></def-item>
###xml 161 164 153 156 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">PKC</term>
###xml 164 180 156 172 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">protein kinase C</p>
###xml 164 180 156 172 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">protein kinase C</p></def>
###xml 161 180 153 172 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">PKC</term><def><p textid="41">protein kinase C</p></def></def-item>
###xml 180 185 172 177 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">SILAC</term>
###xml 185 239 177 231 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">stable isotope labeling of amino acids in cell culture</p>
###xml 185 239 177 231 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">stable isotope labeling of amino acids in cell culture</p></def>
###xml 180 239 172 231 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">SILAC</term><def><p textid="42">stable isotope labeling of amino acids in cell culture</p></def></def-item>
###xml 239 244 231 236 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">TRAF6</term>
###xml 244 294 236 286 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">tumor necrosis factor receptor-associated factor 6</p>
###xml 244 294 236 286 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">tumor necrosis factor receptor-associated factor 6</p></def>
###xml 239 294 231 286 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">TRAF6</term><def><p textid="43">tumor necrosis factor receptor-associated factor 6</p></def></def-item>
###xml 294 298 286 290 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">RIP1</term>
###xml 298 328 290 320 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">receptor-interacting protein 1</p>
###xml 298 328 290 320 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">receptor-interacting protein 1</p></def>
###xml 294 328 286 320 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">RIP1</term><def><p textid="44">receptor-interacting protein 1</p></def></def-item>
###xml 328 334 320 326 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">XIAP-4</term>
###xml 334 374 326 366 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">X-linked inhibitor-of-apoptosis proteins</p>
###xml 334 374 326 366 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">X-linked inhibitor-of-apoptosis proteins</p></def>
###xml 328 374 320 366 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">XIAP-4</term><def><p textid="45">X-linked inhibitor-of-apoptosis proteins</p></def></def-item>
###xml 374 376 366 368 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">ZZ</term>
###xml 376 395 368 387 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">ZZ-type zinc finger</p>
###xml 376 395 368 387 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">ZZ-type zinc finger</p></def>
###xml 374 395 366 387 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">ZZ</term><def><p textid="46">ZZ-type zinc finger</p></def></def-item>
###xml 395 399 387 391 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">MAPK</term>
###xml 399 431 391 423 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">mitogen-activated protein kinase</p>
###xml 399 431 391 423 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">mitogen-activated protein kinase</p></def>
###xml 395 431 387 423 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">MAPK</term><def><p textid="47">mitogen-activated protein kinase</p></def></def-item>
###xml 431 434 423 426 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">TNF</term>
###xml 434 455 426 447 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">tumor necrosis factor</p>
###xml 434 455 426 447 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">tumor necrosis factor</p></def>
###xml 431 455 423 447 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">TNF</term><def><p textid="48">tumor necrosis factor</p></def></def-item>
###xml 455 457 447 449 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G12">Sp</term>
###xml 457 465 449 457 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="49">specific</p>
###xml 457 465 449 457 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="49">specific</p></def>
###xml 455 465 447 457 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G12">Sp</term><def><p textid="49">specific</p></def></def-item>
###xml 465 468 457 460 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G13">nSP</term>
###xml 468 480 460 472 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">nonspecific.</p>
###xml 468 480 460 472 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">nonspecific.</p></def>
###xml 465 480 457 472 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G13">nSP</term><def><p textid="50">nonspecific.</p></def></def-item>
###xml 28 480 28 472 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">IDR</term><def><p textid="38">innate defense regulator</p></def></def-item><def-item><term id="G2">C/EBP</term><def><p textid="39">CCAAT-enhancer-binding protein</p></def></def-item><def-item><term id="G3">NF-&#954;B</term><def><p textid="40">nuclear factor &#954;-light-chain-enhancer of activated B cells</p></def></def-item><def-item><term id="G4">PKC</term><def><p textid="41">protein kinase C</p></def></def-item><def-item><term id="G5">SILAC</term><def><p textid="42">stable isotope labeling of amino acids in cell culture</p></def></def-item><def-item><term id="G6">TRAF6</term><def><p textid="43">tumor necrosis factor receptor-associated factor 6</p></def></def-item><def-item><term id="G7">RIP1</term><def><p textid="44">receptor-interacting protein 1</p></def></def-item><def-item><term id="G8">XIAP-4</term><def><p textid="45">X-linked inhibitor-of-apoptosis proteins</p></def></def-item><def-item><term id="G9">ZZ</term><def><p textid="46">ZZ-type zinc finger</p></def></def-item><def-item><term id="G10">MAPK</term><def><p textid="47">mitogen-activated protein kinase</p></def></def-item><def-item><term id="G11">TNF</term><def><p textid="48">tumor necrosis factor</p></def></def-item><def-item><term id="G12">Sp</term><def><p textid="49">specific</p></def></def-item><def-item><term id="G13">nSP</term><def><p textid="50">nonspecific.</p></def></def-item></def-list>
The abbreviations used are: IDRinnate defense regulatorC/EBPCCAAT-enhancer-binding proteinNF-kappaBnuclear factor kappa-light-chain-enhancer of activated B cellsPKCprotein kinase CSILACstable isotope labeling of amino acids in cell cultureTRAF6tumor necrosis factor receptor-associated factor 6RIP1receptor-interacting protein 1XIAP-4X-linked inhibitor-of-apoptosis proteinsZZZZ-type zinc fingerMAPKmitogen-activated protein kinaseTNFtumor necrosis factorSpspecificnSPnonspecific.
###end p 37
###begin p 38
innate defense regulator
###end p 38
###begin p 39
CCAAT-enhancer-binding protein
###end p 39
###begin p 40
nuclear factor kappa-light-chain-enhancer of activated B cells
###end p 40
###begin p 41
protein kinase C
###end p 41
###begin p 42
stable isotope labeling of amino acids in cell culture
###end p 42
###begin p 43
tumor necrosis factor receptor-associated factor 6
###end p 43
###begin p 44
receptor-interacting protein 1
###end p 44
###begin p 45
X-linked inhibitor-of-apoptosis proteins
###end p 45
###begin p 46
ZZ-type zinc finger
###end p 46
###begin p 47
mitogen-activated protein kinase
###end p 47
###begin p 48
tumor necrosis factor
###end p 48
###begin p 49
specific
###end p 49
###begin p 50
nonspecific.
###end p 50
###begin title 51
Acknowledgment
###end title 51
###begin p 52
We gratefully acknowledge the technical expertise of Mira Jovanovic.
###end p 52
###begin title 53
REFERENCES
###end title 53

